US Advises Pause for J&J COVID-19 Vaccine After Reports of Blood Clots

US Advises Pause for J&J COVID-19 Vaccine After Reports of Blood Clots
A nurse fills a syringe with a dose of Johnson & Johnson's one-dose COVID-19 vaccine at the Vaxmobile, at the Uniondale Hempstead Senior Center, in Uniondale, N.Y., on March 31, 2021. Mary Altaffer/AP Photo
Zachary Stieber
Updated:

U.S. health officials are recommending Johnson & Johnson’s COVID-19 vaccine not be used until an investigation into cases of post-vaccination blood clots is finished.

The six cases, all among women, involve a rare and severe type of clot called cerebral venous sinus thrombosis in combination with low levels of blood platelets, officials told reporters in a call on April 13. One of the patients died while a second is in critical condition at a hospital.

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics